OOIR: Observatory of International Research

Papers

(The TQCC of Pediatric Blood & Cancer is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Comparing Absolute Neutrophil Counts of Children With Sickle Cell Disease With and Without the Duffy Null Phenotype	61
Brochure intervention to manage bothersome taste changes in pediatric patients receiving cancer therapy	50
Palliative care and suicidality: Complicated conversations at two ends of the spectrum	47
	43
Refractory thrombocytopenia and myelofibrosis in a novel KDSR mutation: Case report and literature review	41
Pediatric erythroblastic transformation of JAK2‐mutated prefibrotic primary myelofibrosis with concurrent PHF6 mutations	38
Neonatal giant axillary hemangioma with subclavian arteriovenous fistula and heart failure	36
The role of neoadjuvant chemotherapy in the management of metastatic central nervous system germinoma: A meta‐analysis	35
Image‐Guided Biopsy for the Diagnosis and Molecular Profiling of Hepatoblastoma	31
Bone mineral density in primarily preadolescent children with hemoglobin E/β‐thalassemia with different severities and transfusion requirements	31
Luspatercept for non‐deletional hemoglobin H disease	29
Lactate dehydrogenase reflects the status of ultra‐high‐risk neuroblastoma in a child under treatment	27
Rapid symptomatic improvement in two patients with ganglioglioma after restarting BRAF inhibitor therapy	27
A three‐year‐old with central nervous system graft versus host disease: A rare cause of posthematopoietic stem cell transplant encephalopathy	27
Recombinant von Willebrand factor for perioperative bleeding management in pediatric patient with allergy to plasma‐derived von Willebrand factor	25
Cabozantinib in children with recurrent diffuse gliomas	25
Urgent Chemotherapy for Swift Symptom Relief in Patients With Medulloblastoma	24
How we approach complex vascular anomalies and overgrowth syndromes	24
Efficacy of dual‐task training on stability and function in children with ataxia after medulloblastoma resection: A randomized controlled trial	24
Shwachman–Diamond Syndrome Patient Progressing From Chronic Myelomonocytic Leukemia to Acute Myeloid Leukemia Within Two Months	23
Prevalence of Duffy null and its impact on hydroxyurea in young children with sickle cell disease in the United States	23
	23
Choriocarcinoma in neonates and infants: A severe but curable disease	22
Radiation recall reaction induced by gemcitabine/docetaxel in children: A retrospective study on risk factors and outcomes	22
Improving Implementation of the Psychosocial Standards of Care Together	22

Hemorrhagic Cystitis Following Hematopoietic Stem Cell Transplantation in Children: A Single Pediatric Center Experience	22
Emicizumab in Previously Untreated Patients and Minimally Treated Patients With Hemophilia A: A Comparative Study Between Two International Cohorts	22
Bloodletting as Medical Child Abuse Revealed by Lack of Iron Accumulation Despite Multiple Erythrocyte Transfusions	22
Response assessment by positron emission tomography‐computed tomography as compared with contrast‐enhanced computed tomography in childhood Hodgkin lymphoma can reduce the need for radiotherapy in low	22
Global nLPHL One Working Group (GLOW) Research Roadmap for Nodular Lymphocyte‐Predominant Hodgkin Lymphoma	21
Central nervous system thrombosis in pediatric acute lymphoblastic leukemia in Turkey: A multicenter study	21
Late mortality reduction among survivors of germ cell tumors in childhood and adolescence in Europe: A report from the PanCareSurFup cohort	20
Automating the treatment planning process for 3D‐conformal pediatric craniospinal irradiation therapy	20
Benchmarks for Psychosocial Staffing in Pediatric Oncology: Implementing the Standards Together—Engaging Parents and Providers in Psychosocial Care (iSTEPPP) Study	20
Mini‐hyper CVD + CRIB (condensed rituximab, inotuzumab ozogamicin, and blinatumomab) for refractory pediatric B‐acute lymphoblastic leukemia	20
Late‐onset lymphopenia during radiation is associated with an increased risk of tumor recurrence in newly diagnosed pediatric medulloblastoma	20
No wrong decisions in an all‐wrong situation. A qualitative study on the lived experiences of families of children with diffuse intrinsic pontine glioma	20
After 75 Years of Methotrexate, Can Treatment Results Be Improved With Appropriate Folinic Acid Rescue?	20
Outcomes of Wilms tumor therapy in Lilongwe, Malawi, 2016–2021: Successes and ongoing research priorities	19
	19
Implementation of physical rehabilitation programs for children with cancer across low‐ and middle‐income countries: A need of the hour perspective	19
	18
Metastatic and multiply relapsed SDH‐deficient GIST and paraganglioma displays clinical response to combined poly ADP‐ribose polymerase inhibition and temozolomide	18
Strategies for the Treatment of Desmoplastic Small Round Cell Tumor: A Case Series	18
Carcinomas and Carcinoid Tumors of the Lungs and Bronchi in Children and Adolescents: The EXPeRT Recommendations	18
A National Audit of Current UK Practice on the Use of Anti‐Emetics for Chemotherapy‐Induced Nausea and Vomiting in Children	17
Expanding the Malignancy Spectrum of Tatton‐Brown–Rahman Syndrome: A Case of Hodgkin Lymphoma	17
Prognostic factors of sepsis in children with acute leukemia admitted to the pediatric intensive care unit	17
Impact of Food Insecurity on Malnutrition Treatment Response in Nigerian Children With Sickle Cell Anemia and Severe Acute Malnutrition	17
A Phase 1/2 Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric and Young Adult Solid Tumors	17
Fatal brainstem injury following proton radiation in a patient with medulloblastoma and a germline variant in RNF213	17
New Approaches to Investigate Novel Agents in Ewing Sarcoma: A Report From the Children's Oncology Group Bone Tumor Committee	17
Social determinants of neurocognitive and academic performance in sickle cell disease	17
Psychosexual functioning in cancer survivorship: What the pediatric oncologist needs to know	17
Quality of life and late therapy effects in pediatric non‐Hodgkin lymphoma survivors: Insights from a single‐institution study	17
Platelet changes and bleeding symptoms in children, adolescents, and adults with 22q11.2 deletion syndrome	17
High‐dose carboplatin–irinotecan–temozolomide is an effective salvage chemotherapy for relapsed or refractory neuroblastoma	17
Feasibility of treating pediatric intracranial germ cell tumors in a middle‐income country: The Jordanian experience	17
Feasibility of indocyanine green‐guided localization of pulmonary nodules in children with solid tumors	16
Children's Oncology Group 2023 blueprint for research: Cancer care delivery research	16
Retrospective Analysis of Incidence and Etiology of Severe Infections in Children Receiving Therapy for High‐Risk Neuroblastoma: A Large Single‐Center Experience	16
Dexamethasone for Chemotherapy‐Induced Nausea and Vomiting Prevention in Pediatric Patients: International Consensus	16
Comment on: Investigating Biomarkers for Inborn Errors of Immunity in a Prospective Study of Patients With Autoimmune Cytopenia	16
Improving the Safety and Efficacy of Blood Product Administration in the Pediatric Hematology/Oncology Patient Population	16
Ultrasonographic Monitoring of Cytomegalovirus Gastroenteritis After Hematopoietic Stem Cell Transplantation: A Case Report	16
Unheard and Under‐Supported: Health‐Related Quality of Life in Children, Adolescents, and Young Adults With Sickle Cell Disease	16
First‐Line Postremission Blinatumomab as Successful Toxicity‐Sparing Strategy in a Boy with Cystic Fibrosis and Acute Lymphoblastic Leukemia	16
Significance of fusion status, Oberlin risk factors, local and maintenance treatment in pediatric and adolescent patients with metastatic rhabdomyosarcoma: Data of the European Soft Tissue Sarcoma Reg	16
Ethnic Differences in the Association Between SOD2 rs4880 and Hepatotoxicity in Pediatric Acute Lymphoblastic Leukemia: A Report From the REDIAL Consorti	16
Trametinib Monotherapy in the Treatment of Pediatric Refractory/Relapse Langerhans Cell Histiocytosis	16
B‐cell lymphoblastic leukemia in an adolescent with Dravet syndrome	15
Abnormal coronary hyperperfusion due to a giant hemangioendothelioma in fetal distress: A case report	15
Desensitization with daratumumab in a pediatric patient with thalassemia major and high donor‐specific antibody prior to haploidentical transplantation	15
Posterior Mediastinal Tumor Presenting with Compressive Myelopathy: Uncommon Site for a Rare Tumor	15
Uniting for Change: The GLOW Initiative and Its Impact on Nodular Lymphocyte‐Predominant Hodgkin Lymphoma	15

Unraveling Juvenile Hyaline Fibromatosis: A Case of Novel ANTXR2 Mutations Associated with Subcutaneous Masses and Hydronephrosis	15
Allogenic haematopoeitic stem cell transplant as cure for severe transfusion‐dependent non‐dominant hereditary spherocytosis due to homozygous SPTA1 mutation	15
Comment on: Incorporation of patient‐reported outcomes in early‐phase clinical trials for childhood and adolescent cancer	15
Novel ELANE mutation causing severe congenital neutropenia with unpredictable fluctuations in neutrophil counts	15
Bone marrow hematoidin crystals in a pediatric patient with chondroblastic osteosarcoma	15
Parental Acceptance of Human Papillomavirus Vaccination Among Females Treated for Childhood Cancer and/or With Hematopoietic Stem Cell Transplantation: A Cross‐Sectional Study	15
Ring sideroblasts and macrocytic anemia in an infant: Clues to the diagnosis of Pearson syndrome	15
Issue Information	15
Paraneoplastic Ichthyosis Preceding the Diagnosis of Gluteal Rhabdomyosarcoma at Initial Presentation and Relapse	15
Case report: Dichloroacetate‐induced methaemoglobinaemia in a G6PD‐deficient neonate	15
Prognostic value of texture analysis of the primary tumour in high‐risk neuroblastoma: An ¹⁸F‐DOPA PET study	14
Thrombin activatable fibrinolysis inhibitor plasma levels and TAFI Thr325Ile genetic polymorphism in a cohort of Egyptian sickle cell disease patients and impact on disease severity	14
Dyadic coping experiences of parents of children with vascular anomalies	14
	14
Epidemiology of clinically unsuspected venous thromboembolism in children with cancer: A population‐based study from Maritimes, Canada	14
A proposed algorithm for evaluation and management of pediatric hemophilia patients who present to the emergency department with head trauma	14
Wilms tumor characteristics, surgical management, outcomes, and chronic kidney disease in children with WAGR syndrome: A report from the International WAGR Syndrome Association survey	14
The Role of Perceived Health‐Related Information Adequacy in the Experiences of Parents of Children With Complex Vascular Anomalies	14
SNAP: Supportive non‐invasive ventilation for acute chest syndrome prevention for hospitalized children with sickle cell disease: Perspectives of patients, parents, and the healthcare team	14
Use of Autologous Umbilical Cord Blood in Neonatal Cardiac Surgery: A European Survey of Current Practices and Perceptions	14
Parental Perspectives on an Educational Tool for Values‐Informed Biobanking Consent in Pediatric Oncology: A Pilot Project	13
A Case of Blinatumomab Efficacy in RAM Immunophenotype/ CBFA2T3::GLIS2 Fusion AML	13
Pazopanib Combined With Vincristine and Irinotecan in Relapsed Wilms Tumor: Encouraging Outcomes in a Heavily Pretreated Pediatric Cohort	13
Neurologic Morbidity in Survivors of Childhood Hodgkin Lymphoma Treated With Radiation	13
Baseline Characteristics of Parents Enrolled in Children's Oncology Group Study ACCL20N1CD: Financial Toxicity During Treatment for Pediatric Acute Lymphoblastic Leukemia in the United States	13
Sickle Cell Disease Is an Inherent Risk for Asthma in a Sibling Comparison Study	13
Dual Use of Skeletal Muscle Index and Body Mass Index Measured at the Time of Diagnosis Predicts Prognosis in Children With Malignant Solid Tumors: A Single‐Center Retrospective Study	13
CIC–NUTM1 sarcoma in an 8‐year‐old female patient with a new fusion: A case report	13
Image‐defined risk factors in localized thoracic neuroblastoma and ganglioneuroma	13
Malignant Rhabdoid Tumors of the Liver Are Associated With Inferior Outcomes Compared to Other Extracranial Rhabdoid Tumors	13
Unicentric Castleman Disease as a Sufficient and Reversible Cause of Steroid‐Refractory Autoimmune Hemolytic Anemia in a Child	13
Isolated Dermal Arteriolar Thrombosis in a Pediatric Patient: A Rare Complication During Eltrombopag Therapy for Chronic Immune Thrombocytopenia	13
Shifting perspectives and transformative change: Parent perspectives of an active music engagement intervention for themselves and their child with cancer	13
Inclusion of Optic Pathway and Hypothalamic Tumors in Prognostic Studies of Pilocytic Astrocytoma: Is It Justified?	13
Vincristine Anaphylaxis and Rapid Drug Desensitisation	13
Refractory, fatal autoimmune hemolytic anemia due to ineffective thymic‐derived T‐cell reconstitution following allogeneic hematopoietic cell transplantation for hypomorphic RAG1 deficiency	13
Integrating Palliative Care in Phase 1 Pediatric Oncology Trials: Parent Perspectives	13
Treatment Landscape in Pediatric Immune Thrombocytopenia: Addressing Unmet Needs	13
Inpatient Food Insecurity and Pediatric Hematology Oncology Hospitalization Outcomes	13
Concurrent carcinocythemia, chest wall and right knee joint involvement in Ewing sarcoma	13
How we approach coagulopathy with vascular anomalies	13
Variant histology of pediatric nodular lymphocyte‐predominant Hodgkin lymphoma with IgD and CD30 expression	12
A qualitative exploration of parental caregivers’ experience caring for children who have survived medulloblastoma	12
Corrigendum	12
Age‐ and sex‐specific rates of gall bladder disease in children with sickle cell disease	12
Pediatric Mixed Phenotype Acute Leukemia With ETV6 :: ARNT Fusion Gene Successfully Treated by Allogeneic	12
Genetic characteristics and treatment outcome in infants with KMT2A germline B‐cell precursor acute lymphoblastic leukemia: Results of MLL‐Baby protocol	12
Correction to: Applying the COM‐B model to patient‐reported barriers to medication adherence in pediatric acute lymphoblastic leukemia	12
Assessment of Caregivers and Their Children With Cancer Regarding Information Provided by Healthcare Teams: Advancing Stages Toward the Creation of a Structured Education Program at the National Level	12
Incidence and survival for childhood cancer by endorsed non‐stage prognostic indicators in Australia	12
Wiskott–Aldrich syndrome protein expression in female WAS carriers: A flow cytometry study from North India	12
Stomatocytes, a whistleblower for future familial cardiovascular events: Unraveling the diagnosis of sitosterolemia in an Indian family	12
Diminished ovarian reserve in adolescent cancer survivors treated with heavy metal chemotherapy	12
Sarcopenia in long‐term survivors of cancer in childhood and adolescence: A cross‐sectional study of calf muscle mass by peripheral quantitative computed tomography with an examination of the muscle–b	11
Clinical Characteristics and Prognostic Risk Factors for Pediatric B‐Cell Lymphoblastic Lymphoma: A Multicenter Retrospective Cohort Study for China Net Childhood Lymphoma	11
Comment on: Trends in blood transfusion, hydroxyurea use, and iron overload among children with sickle cell disease enrolled in Medicaid, 2004–2019. Emerging therapeutic options for sickle cell anemia	11
Challenge implementing Pediatric Early Warning Systems to improve early identification of clinical deterioration in hospitalized children with cancer: Is it the score?	11
Cyclin D2 gene variance and expression level in pediatric acute lymphoblastic leukemia	11
Daratumumab‐induced minimal residual disease negative remission in CD38 (dim)‐positive pediatric acute myeloid leukemia	11
Issue Information	11
Prognostic value of chest x‐ray‐ and CT‐defined large mediastinal adenopathy in high‐risk pediatric Hodgkin lymphoma: A report from the Children's Oncology Group Study AHOD0831	11
Development and Validation of an Automated Pediatric Cancer Staging Calculator Using the Toronto Pediatric Cancer Stage Guidelines	11
A novel mobile health application to support cancer surveillance needs of patients and families with cancer predisposition syndromes	11
Thalidomide‐associated autoimmune hemolytic anemia	11
Abstracts from the 39^th Annual Meeting of the Histiocyte Society	11
Use of milrinone to support therapy‐induced heart failure through hematopoietic stem cell transplantation in a pediatric patient with high‐risk FLT3+ acute myeloid leukemia	11
Introduction to fertility preservation in pediatric patients with cancer: A report from the Children's Oncology Group	11
Clinical, Psychosocial, and Care Coordination Concerns in Macrocephaly Capillary Malformation Syndrome: Insights From a Large International Survey	11
Family Perspectives on Pediatric Complementary and Integrative Medicine Practices in Pediatric Hematology and Oncology	11
Spontaneous regression of a greater than 5 cm infant neuroblastoma after a three‐fold volume increase without life‐ or organ‐threatening features	11
Socioeconomic Factors Associated With Participation in Postmortem Tissue Donation in Pediatric Central Nervous System Tumors	11
Characterization of KMT2A::MATR3 fusion in a patient with acute lymphoblastic leukemia and monitoring of minimal residual disease by nanoplate digital PCR	11
FANCC and PTCH1 gene loss in congenital infantile rhabdomyosarcoma with spindle cell features	11
Pediatric Acute B‐Lymphoblastic Leukemia Presenting as Hypereosinophilia With Lung Involvement and Elevated Immunoglobulin E Levels	11
The evidence is mounting: Insurance coverage disruptions lead to worse outcomes among children diagnosed with cancer	11
Optimizing Options for Future Third‐Party Reproduction Among Youth Newly Diagnosed With Cancer: Considerations for Pediatric Fertility Preservation Counseling	11
Effects of a Low Versus Moderate–High Intense Exercise Program on Innate Immune Recovery, Fitness, and Quality of Life During Pediatric Allo‐HSCT—The ANIMAL Exploratory Randomized Controlled Trial	10
Pulmonary hypertension screening in children with sickle cell disease	10
Efficacy and safety of azacitidine in pediatric patients with newly diagnosed advanced myelodysplastic syndromes before hematopoietic stem cell transplantation in the AZA‐JMML‐001 trial	10
Pre‐transplant glomerular hyperfiltration is not a risk factor for increased renal morbidity and mortality in pediatric stem cell transplant patients	10

Anything to Help	10
NCI intramural program approach to rare tumors: Natural history study of rare solid tumors in children and adults: A longitudinal, comprehensive data and biospecimen collection protocol	10
Surgical aspects and outcomes after nephrectomy for Wilms tumour in sub‐Saharan Africa: A report from Wilms Africa Phase II—CANCaRe Africa	10
Neuroblastoma with neonatal cardiogenic shock and multiple‐organ failure: A rare association	10
De novo antiphospholipid antibody syndrome in two infants	10
B‐Lymphoblastic Leukemia With TCF3::PBX1 Fusion Presenting a Mature B‐Cell Phenotype and Lambda Light‐Chain Restriction	10
Correction to “A National Audit of Current UK Practice on the Use of Anti‐Emetics for Chemotherapy‐Induced Nausea and Vomiting in Children”	10
Contemporary Biology, Management, and Outcomes of Renal Medullary Carcinoma in Children and Adults: A Pediatric Surgical Oncology Research Collaborative Study	10
Transatlantic progress in measurement of cognitive outcomes in paediatric oncology trials	10
Spinal Atypical Teratoid/Rhabdoid Tumor with Metastatic Lesions in the Bilateral Acoustic Nerves	10
Issue Information	10
Associations between Medicaid enrollment and diagnosis stage and survival among pediatric cancer patients	10
How we approach genetics in the diagnosis and management of vascular anomalies	10
Chemo‐Immunotherapy Rescue for High‐Risk Neuroblastoma Patients With Progressive Disease Before High‐Dose Chemotherapy: Real‐World Data From the SACHA‐France Study	10
Successful hematopoietic stem cell transplantation in MYH9‐related congenital thrombocytopenia	10
Post‐Transplant Cyclophosphamide for Graft‐Versus‐Host Disease Prophylaxis in Pediatric Stem Cell Transplantation	10
Comparison of transfusion reactions in children and adults: A systematic review and meta‐analysis	10
Blood counts in children with Down syndrome	10
How we approach lymphedema in the pediatric population	10
Feasibility of telehealth exercise and nicotinamide riboside supplementation in survivors of childhood cancer at risk for diabetes: A pilot randomized controlled trial	10
Correction to ‘Congenital Langerhans Cell Histiocytosis With Novel KLC1::RAF1 Gene Fusion Identified Through Routine Whole‐Genome Sequencing’	10
Comment on: A Comparative Analysis of Clinical Utility of Cytogenetics and Copy‐Number–Integrated Risk Stratification Scores in a Prospective Cohort of Pediatric B‐Cell Acute Lymphoblastic Leukemia	10
Provision of a personalized survivorship care plan and its impact on cancer‐related health literacy among childhood cancer survivors in Hong Kong	10
Results of a Randomized Augmented Intensification Phase in Acute Lymphoblastic Leukemia in Children in Argentina: GATLA 2010 ALL IC Trial	10
Good engraftment after reduced intensity targeted busulfan‐based conditioning and matched related donor hematopoietic cell transplantation in hemoglobinopathies	10
Pediatric refractory immune thrombocytopenia: A systematic review	10
Sirolimus for management of GI bleeding in blue rubber bleb nevus syndrome: A case series	10
Marginal Zone B‐Cell Lymphoma With Marked Plasmacytic Differentiation and Increased Large Cells in a Teenage Male With Serine/Threonine Kinase‐4 Deficiency	10
How We Approach Central Venous Access in Pediatric Hematology–Oncology: A Workflow‐Based Strategy to Support Treatment Continuity	10
Clinic reported facilitators and barriers to pediatric cancer survivor care delivery among survivorship clinics: A fishbone analysis	9
Can you hear me now? Tools for cultivating a culture of respect, value, and appreciation within pediatric hematology, oncology, and cellular therapy	9
Correlation between asparaginase enzyme activity levels and coagulation parameters during childhood acute lymphoblastic leukemia treatment	9
Diagnosis and management of isolated neutropenia: A survey of pediatric hematologist oncologists	9
How We Approach Intraocular Retinoblastoma in 2026: Agreement and Disagreement in Four Referral Centers in the USA and Europe	9
Hyperthyroidism following transplantation and SARS‐CoV‐2 exposure	9
Clinical Practice Guideline for the Management of Communication and Swallowing in Children Diagnosed With Childhood Brain Tumor or Leukemia	9
Heterozygous TCF3‐related disease presenting as X‐linked agammaglobulinemia mimicry in a male toddler with B‐cell aplasia, agammaglobulinemia, and severe neutropenia	9
Pain mitigation and management strategies for anti‐GD2 infusions: An expert consensus	9
The Global Prevalence of Iron Deficiency in Collegiate Athletes: A Systematic Review and Meta‐Analysis	9
EZH2 is a key component of hepatoblastoma tumor cell growth	9
	9
Primary Laparoscopic Nephrectomy for a Rare Renal Tumor in a Pediatric Patient	9
Erratum	9
Comprehensive fertility preservation can be offered in a timely manner around gonadotoxic therapy in children and adolescents	9
The quality and content analysis of YouTube videos about chemotherapy for children	9
Acute Liver Failure in a 17‐Year‐Old Boy Caused by a Blastic Plasmacytoid Dendritic Cell Neoplasm With a Novel MYB Rearrangement	9
An SRF‐rearranged malignant cellular myoid neoplasm with a novel SRF–MKL2 fusion	9
Expansion of the Phenotype of Lymphatic Anomalies Caused by Somatic Activating BRAF Variant	9
Behavioral and Electrophysiological Assessment of Central Auditory Processing in Individuals With Sickle Cell Disease	9
Bilirubin crystals in neutrophils of a newborn with Rh incompatibility	9
Eculizumab for management of hyperhemolysis syndrome in pediatric patients with sickle cell disease: A single‐center case series	9
Myeloproliferative neoplasm with eosinophilia and PDGFR beta rearrangement in an infant	9
Risk of Metabolic Syndrome and Glucose Homeostasis Among Childhood and Young Adult Acute Lymphoblastic Leukemia Survivors: Part of the ALL‐STAR Study	9
Systemic Inflammatory Response Post Alemtuzumab and Low‐Dose Total Body Irradiation in Pediatric Patients With Sickle Cell Disease: A Case Series	9
A comprehensive assessment of the prolonged febrile neutropenia evaluation in pediatric oncology patients	9
Reply to: Comment on: Membrane‐type 1 matrix metalloproteinase as predictor of survival and candidate therapeutic target in Ewing sarcoma	9
Reducing the Diagnostic Time for Childhood Cancer in Peru: A Hospital‐Based Registry Analysis Four Years After Implementation of the Global Initiative for Childhood Cancer	9
The pervasive influence of systems of power on transition readiness for adult care in sickle cell disease: A qualitative study	9
Philadelphia chromosome‐like B‐acute lymphoblastic leukemia and disseminated juvenile xanthogranulomatosis with shared KRAS mutation	9
Can virtual care reduce treatment burden in pediatric leukemia? A retrospective cost analysis	9
	9
Treatment of high‐risk Hodgkin lymphoma with a modified Stanford V regimen in the AHOPCA: Substituting chemotherapy agents and hampered outcomes	9
Treatment of newly diagnosed severe aplastic anemia in children: Evidence‐based recommendations	9
Impact of magnetic resonance angiography parameters on stroke prevention therapy in pediatric patients with sickle cell anemia	9
Communication, academic and social outcomes of childhood cancer survivors with hearing loss: A systematic review	9
Longitudinal Patterns of Fatigue in Long‐Term Survivors of Childhood and Adolescent Cancers: A Report From the Swiss Childhood Cancer Survivor Study	9
A congenital CSF3R mutation in chronic neutropenia reveals a vital role for a cytokine receptor extracellular hinge motif in the response to granulocyte colony‐stimulating factor	9
Atypical presentations of RECQL4‐related syndromes	9
Myelodysplastic syndrome in a patient with Barth syndrome (3‐methylglutaconic aciduria type II)	9
Long‐term outcomes among survivors of childhood osteosarcoma: A report from the Childhood Cancer Survivor Study (CCSS)	9
Pediatric Hematology Oncology Building Education and Training Success (PHO BEATS): A Conference to Raise Awareness and Interest for Residents and Medical Students	9
New therapeutics for children with sickle cell disease: A time for celebration, caution, or both?	9
Lack of benefit from premedication for pegylated asparaginase during pediatric acute lymphoblastic leukemia/lymphoma therapy: A side‐by‐side comparison	9
Associations Between Pain Scores and Opioid Doses With Emergency Department Disposition and Return Visit Rates in Children With Sickle Cell Disease	9
Contemporary surgical management of pediatric non‐rhabdomyosarcoma soft tissue sarcoma	9
Two Surveys, 16 Years Apart: Comparing Traditional and Complementary Medicine Use by Children With Cancer in Jordan	9
Evaluation of financial relationships between Japanese certified pediatric hematologist/oncologists and pharmaceutical companies: a cross‐sectional analysis of personal payments from pharmaceutical co	9
Cytarabine‐Related Neurotoxicity in an Infant With Acute Lymphoblastic Leukemia	9
Modern surgical strategies in pediatric neuroblastoma: Evolving approaches and treatment principles	9
Episodes of acute methotrexate‐related neurotoxicity linked to compromised long‐term neurocognitive function	9
Intra‐abdominal desmoplastic small round cell tumor: The European pediatric Soft tissue sarcoma Study Group (EpSSG) experience	9
Correction to “Salvage Therapy Efficacy is Modified by Risk Group at Diagnosis in Patients With Relapsed Rhabdomyosarcoma”	9
An Overview of Cannabinoid Interactions With Common Pediatric Antineoplastic Agents	9
Time to diagnosis among young patients with cancer	9
The Dangerousness of a Devilled Egg	9
Non‐Promyelocytic Acute Myeloid Leukaemia With Budd–Chiari Syndrome: A Rare Concurrence in a Child	8
A Novel Gain‐of‐Function RAC2 Variant (p.Y64H) Associated With Lymphopenia and Leukopenia	8
PAX–FOXO1 fusion status in children and adolescents with alveolar rhabdomyosarcoma: Impact on clinical, pathological, and survival features	8
Scaling‐Up Research in Childhood Cancer in Low‐ and Middle‐Income Countries	8
X‐Linked Sideroblastic Anemia Caused by ALAS2 Intron 1 Mutation Successfully Treated by Allogenic Hematopoietic Stem Cell Transplant	8
Prognostic value of hemogram parameters in osteosarcoma: The French OS2006 experience	8
Effects of COVID‐19 vaccination on platelet counts and bleeding in children, adolescents, and young adults with immune thrombocytopenia	8
Use of gemcitabine, oxaliplatin, and anti‐CD20 therapy in children and adolescents with non‐Hodgkin lymphoma unfit for intensive therapy	8
Pathogenic Germline PALB2 and RAD50 Variants in Patients With Relapsed Ewing Sarcoma	8
Clinical Characteristics and Prognostic Analysis of Non‐ NPM1‐ALK Fusions in Pediatric Patients With ALK‐Positive Anaplastic Large‐Cell Lymphoma: A Singl	8